Connection

Jean-Charles Soria to Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Protein-Tyrosine Kinases.
Jean-Charles Soria
Connection Strength
0.468
Protein-Tyrosine Kinases
  1. Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2018 01 11; 378(2):113-125.
    View in: PubMed
    Score: 0.159
  2. First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours. Eur J Cancer. 2017 08; 81:142-150.
    View in: PubMed
    Score: 0.156
  3. Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition. Cancer Treat Rev. 2017 Apr; 55:83-95.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.